Thomas S. Lam - 02 Nov 2021 Form 4 Insider Report for Apollo Medical Holdings, Inc. (AMEH)

Role
President and Co-CEO, Director
Signature
/s/ Thomas S. Lam
Issuer symbol
AMEH
Transactions as of
02 Nov 2021
Net transactions value
$0
Form type
4
Filing time
04 Nov 2021, 20:25:54 UTC
Next filing
02 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMEH Common Stock Award $0 +65,242 +52% $0.000000 191,827 02 Nov 2021 Direct
holding AMEH Common Stock 908,183 02 Nov 2021 By the Thomas and Jeanette Lam 2002 Family Trust F1
holding AMEH Common Stock 564,691 02 Nov 2021 By grantor retained annuity trust F2
holding AMEH Common Stock 564,691 02 Nov 2021 By wife F3
holding AMEH Common Stock 10,925,702 02 Nov 2021 By Allied Physicians of California, a Professional Medical Corporation F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMEH Stock Option (right to buy) Award $0 +29,502 $0.000000 29,502 02 Nov 2021 Common Stock 29,502 $71.45 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held by the Thomas and Jeanette Lam 2002 Family Trust U/A dated 09/06/2002. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F2 These securities are held by a grantor retained annuity trust for the benefit of the Reporting Person and his children. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3 These securities are beneficially owned by the Reporting Person's spouse as separate property. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
F4 These securities are beneficially owned by Allied, of which the Reporting Person is a director, officer and shareholder. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F5 Provided the Reporting Person is still employed with the Issuer on the following dates, the option shall vest in three equal annual installments commencing on the first anniversary of November 2, 2021.